AbbVie, Lilly atopic dermatitis hopefuls hit with more delays as FDA’s JAK inhibitor holdups carry on

AbbVie, Lilly atopic dermatitis hopefuls hit with more delays as FDA’s JAK inhibitor holdups carry on
nhigginsdunn
Fri, 07/16/2021 – 11:17